1-2 of 2
Selvarangan Ponnazhagan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Systemic Checkpoint Blockade by PD-L1 Single-Chain Antibody Confers Potent Antitumor Immunity and Long-term Survival

Hong Wang, Vinayak Khattar, Jonathan A. Hensel, Reading Ashton, Yun Lu, Anna G. Sorace, Yong Wang, Jessy S. Deshane, Joshua L. Mieher, Champion Deivanayagam, Selvarangan Ponnazhagan
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (11): 1710–1721.
https://doi.org/10.1158/1535-7163.MCT-22-0010
Published: 03 November 2022
View article titled, Systemic Checkpoint Blockade by PD-L1 Single-Chain Antibody Confers Potent Antitumor Immunity and Long-term Survival
Open the PDF for Systemic Checkpoint Blockade by PD-L1 Single-Chain Antibody Confers Potent Antitumor Immunity and Long-term Survival in another window
Includes: Supplementary data
Journal Articles

RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity

Hong Wang, Reading Ashton, Jonathan A. Hensel, Joo Hyoung Lee, Vinayak Khattar, Yong Wang, Jessy S. Deshane, Selvarangan Ponnazhagan
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (12): 2585–2597.
https://doi.org/10.1158/1535-7163.MCT-20-0378
Published: 02 December 2020
View article titled, RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
Open the PDF for RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity in another window
Includes: Supplementary data